Measuring response with FDG-PET: Methodological aspects

Martin Allen-Auerbach; Wolfgang A. Weber

doi:10.1634/theoncologist.2008-0119

Measuring response with FDG-PET: Methodological aspects

Martin Allen-Auerbach, Wolfgang A. Weber

David Geffen School of Medicine at UCLA

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment.

Original language	English
Pages (from-to)	369-377
Number of pages	9
Journal	Oncologist
Volume	14
Issue number	4
DOIs	https://doi.org/10.1634/theoncologist.2008-0119
State	Published - Apr 2009
Externally published	Yes

Keywords

Chemotherapy
Fluorodeoxyglucose
Positron emission tomography
Radiotherapy
Response

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1634/theoncologist.2008-0119

Cite this

@article{0aad3514da5e4177b364fed22ee7154b,

title = "Measuring response with FDG-PET: Methodological aspects",

abstract = "The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment.",

keywords = "Chemotherapy, Fluorodeoxyglucose, Positron emission tomography, Radiotherapy, Response",

author = "Martin Allen-Auerbach and Weber, {Wolfgang A.}",

year = "2009",

month = apr,

doi = "10.1634/theoncologist.2008-0119",

language = "English",

volume = "14",

pages = "369--377",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Measuring response with FDG-PET

T2 - Methodological aspects

AU - Allen-Auerbach, Martin

AU - Weber, Wolfgang A.

PY - 2009/4

Y1 - 2009/4

N2 - The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment.

AB - The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment.

KW - Chemotherapy

KW - Fluorodeoxyglucose

KW - Positron emission tomography

KW - Radiotherapy

KW - Response

UR - http://www.scopus.com/inward/record.url?scp=66249085519&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2008-0119

DO - 10.1634/theoncologist.2008-0119

M3 - Article

C2 - 19357228

AN - SCOPUS:66249085519

SN - 1083-7159

VL - 14

SP - 369

EP - 377

JO - Oncologist

JF - Oncologist

IS - 4

ER -

Measuring response with FDG-PET: Methodological aspects

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this